Subsidiary23 Apr 2026, 01:16 pm
Alembic Pharma incorporates wholly-owned subsidiary in Germany
AI Summary
Alembic Pharmaceuticals Ltd has incorporated a wholly-owned subsidiary named Alembic Pharmaceuticals GmbH in Germany. The new entity has a share capital of EUR 25,000, divided into 25,000 shares of EUR 1.00 each. It belongs to the pharmaceuticals industry and is yet to commence business operations, therefore its current turnover is nil. The strategic objective behind this incorporation is to explore new business opportunities in Germany, focusing on the promotion, sale, and distribution of Alembic Pharmaceuticals' products in that region. This transaction is not considered a related party transaction, and Alembic Pharmaceuticals Ltd holds a 100% stake in the newly formed subsidiary.
Key Highlights
- Alembic Pharma incorporated a wholly-owned subsidiary in Germany.
- The new entity, Alembic Pharmaceuticals GmbH, has EUR 25,000 share capital.
- It aims to promote, sell, and distribute pharma products in Germany.
- This strategic move expands the company's international presence.